UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
BJU international, ISSN 1464-4096, 11/2012, Volume 110, Issue 10, pp. 1426 - 1435
laparoscopy | ureterectomy | minimally invasive techniques | nephroureterectomy | transitional cell carcinoma | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Tumors of the urinary system | Urinary tract. Prostate gland | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Urinary system involvement in other diseases. Miscellaneous | Carcinoma, Transitional Cell - mortality | Urologic Surgical Procedures | Humans | Carcinoma, Transitional Cell - secondary | Neoplasm Recurrence, Local | Ureteral Neoplasms - pathology | Survival Rate | Laparoscopy | Kidney Neoplasms - mortality | Ureter - surgery | Disease-Free Survival | Kidney Neoplasms - surgery | Nephrectomy | Kidney Neoplasms - pathology | Carcinoma, Transitional Cell - surgery | Ureteral Neoplasms - mortality | Ureteral Neoplasms - surgery | Laparoscopic surgery | Cancer | Confidence intervals | Software reviews | Surgical techniques | Urogenital system | Index Medicus
Journal Article
Cancer, ISSN 0008-543X, 2009, Volume 115, Issue 13, pp. 2881 - 2890
lapatinib | HER‐2 | transitional cell carcinoma | bladder cancer | epidermal growth factor receptor | dual tyrosine kinase inhibitor | Life Sciences & Biomedicine | Oncology | Science & Technology | Tumors of the urinary system | Urinary tract. Prostate gland | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Tumors | Administration, Oral | Humans | Middle Aged | Carcinoma, Transitional Cell - secondary | Male | Treatment Outcome | Urinary Bladder Neoplasms - secondary | Urinary Bladder Neoplasms - drug therapy | Disease Progression | Platinum Compounds - therapeutic use | Carcinoma, Transitional Cell - pathology | Time Factors | Quinazolines - therapeutic use | Carcinoma, Transitional Cell - drug therapy | Quinazolines - adverse effects | Survival Analysis | Urinary Bladder Neoplasms - pathology | Adult | Female | Quinazolines - administration & dosage | Aged | Adenocarcinoma | Care and treatment | Research | Bladder cancer | Patient outcomes | Index Medicus | Abridged Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 09/2009, Volume 27, Issue 27, pp. 4454 - 4461
Urologic Neoplasms - secondary | Humans | Middle Aged | Carcinoma, Transitional Cell - secondary | Palliative Care | Antineoplastic Agents - administration & dosage | Vinblastine - administration & dosage | Disease Progression | Urothelium - pathology | Urologic Neoplasms - drug therapy | Vinblastine - analogs & derivatives | Carcinoma, Transitional Cell - drug therapy | Survival Analysis | Aged | Platinum Compounds - administration & dosage | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 04/2010, Volume 28, Issue 11, pp. 1850 - 1855
Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Medical sciences | Tumors | Prognosis | Prospective Studies | Humans | Middle Aged | Risk Factors | Carcinoma, Transitional Cell - secondary | Hemoglobins - metabolism | Male | Survival Rate | Urinary Bladder Neoplasms - drug therapy | Clinical Trials, Phase III as Topic | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Treatment Failure | Carcinoma, Transitional Cell - drug therapy | Urinary Bladder Neoplasms - pathology | Aged, 80 and over | Adult | Female | Aged | Neoplasm Staging | Organoplatinum Compounds - therapeutic use | Index Medicus
Journal Article
Neurology, ISSN 0028-3878, 02/2020, Volume 94, Issue 5, pp. e521 - e528
Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Small Cell Lung Carcinoma - cerebrospinal fluid | Humans | Middle Aged | Carcinoma, Transitional Cell - secondary | ErbB Receptors - genetics | Ovarian Neoplasms - pathology | Carcinoma, Non-Small-Cell Lung - cerebrospinal fluid | Lung Neoplasms - pathology | Male | Carcinoma, Non-Small-Cell Lung - diagnosis | Meningeal Carcinomatosis - secondary | Carcinoma - cerebrospinal fluid | Meningeal Carcinomatosis - genetics | Epithelial Cell Adhesion Molecule | Small Cell Lung Carcinoma - secondary | Gastrointestinal Neoplasms - pathology | Carcinoma, Non-Small-Cell Lung - secondary | Flow Cytometry | Sensitivity and Specificity | Carcinoma, Lobular - cerebrospinal fluid | Aged, 80 and over | Meningeal Carcinomatosis - cerebrospinal fluid | Adult | Female | Carcinoma, Ductal, Breast - cerebrospinal fluid | Carcinoma, Transitional Cell - cerebrospinal fluid | Carcinoma, Ductal, Breast - secondary | Carcinoma - secondary | Carcinoma, Lobular - secondary | Lung Neoplasms - genetics | Meningeal Carcinomatosis - diagnosis | Carcinoma, Non-Small-Cell Lung - genetics | Carcinoma, Transitional Cell - diagnosis | Carcinoma - diagnosis | Carcinoma, Lobular - diagnosis | Carcinoma, Ductal, Breast - diagnosis | Magnetic Resonance Imaging | Breast Neoplasms - pathology | Neoplastic Cells, Circulating | Small Cell Lung Carcinoma - diagnosis | Aged | Index Medicus | Abridged Index Medicus
Journal Article
Open veterinary journal (Tripoli, Libya), ISSN 2226-4485, 01/2020, Volume 9, Issue 4, pp. 313 - 316
Journal Article
Open veterinary journal (Tripoli, Libya), 01/2020, Volume 9, Issue 4, p. 313
Journal Article
European urology, ISSN 0302-2838, 2011, Volume 60, Issue 5, pp. 1066 - 1073
Urology | Robotic surgery | Transitional cell carcinoma | Radical cystectomy | Bladder cancer | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Tumors of the urinary system | Urinary tract. Prostate gland | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Urinary system involvement in other diseases. Miscellaneous | Carcinoma, Transitional Cell - mortality | Lymph Node Excision | Cystectomy - mortality | Humans | Middle Aged | Carcinoma, Transitional Cell - secondary | Male | Cystectomy - adverse effects | Robotics | Surgery, Computer-Assisted - adverse effects | Sweden | Neoplasm Grading | Time Factors | Urinary Bladder Neoplasms - pathology | Adult | Female | Learning Curve | Urinary Diversion - adverse effects | Clinical Competence | Urinary Bladder Neoplasms - mortality | Neoplasm Invasiveness | Surgery, Computer-Assisted - mortality | Kaplan-Meier Estimate | Survival Rate | Treatment Outcome | Urinary Bladder Neoplasms - surgery | Aged | Carcinoma, Transitional Cell - surgery | Cystectomy - methods | Adenocarcinoma | Care and treatment | Robotics industry | Robots | Index Medicus | Medicin och hälsovetenskap
Journal Article
BJU international, ISSN 1464-4096, 09/2016, Volume 118, Issue 3, pp. 408 - 415
BEZ235 | mTOR inhibitor | transitional cell carcinoma | PI3K inhibitor | Transitional cell carcinoma | MTOR inhibitor | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Prospective Studies | Humans | Middle Aged | Carcinoma, Transitional Cell - secondary | Male | Antineoplastic Agents - therapeutic use | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | TOR Serine-Threonine Kinases - antagonists & inhibitors | Urologic Neoplasms - pathology | Urologic Neoplasms - drug therapy | Carcinoma, Transitional Cell - pathology | Carcinoma, Transitional Cell - drug therapy | Adult | Female | Aged | Quinolines - therapeutic use | Imidazoles - therapeutic use | Adenocarcinoma | Clinical trials | Care and treatment | Metastasis | Index Medicus
Journal Article
10.
Full Text
Recurrence Patterns After Open and Robot-assisted Radical Cystectomy for Bladder Cancer
European urology, ISSN 0302-2838, 2015, Volume 68, Issue 3, pp. 399 - 405
Urology | Recurrence | Local | Open radical cystectomy | Bladder cancer | Robot-assisted radical cystectomy | Distant | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Adenocarcinoma - pathology | Lymph Nodes - pathology | Peritoneal Neoplasms - epidemiology | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Carcinoma, Transitional Cell - secondary | Carcinoma, Squamous Cell - surgery | Male | Female | Retrospective Studies | Peritoneal Neoplasms - secondary | Robotic Surgical Procedures | Proportional Hazards Models | Treatment Outcome | Laparoscopy | Urinary Bladder Neoplasms - surgery | Adenocarcinoma - secondary | Carcinoma, Transitional Cell - pathology | Urinary Bladder Neoplasms - parasitology | Carcinoma, Squamous Cell - secondary | Aged | Neoplasm Recurrence, Local - epidemiology | Carcinoma, Transitional Cell - surgery | Cystectomy - methods | Adenocarcinoma - surgery | Cohort Studies | Robotic surgery | Medical colleges | Robots | Index Medicus
Journal Article
European urology, ISSN 0302-2838, 2016, Volume 71, Issue 3, pp. 462 - 475
Urology | Cystectomy | Treatment | Multimodality | EAU | Metastatic | Muscle invasive | Diagnosis | Bladder cancer | Follow-up | Guidelines | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Neoplasm Invasiveness | Europe | Humans | Carcinoma, Transitional Cell - secondary | Cystoscopy | Carcinoma, Transitional Cell - therapy | Urinary Bladder - pathology | Radiotherapy | Neoplasm Metastasis | Societies, Medical | Carcinoma, Transitional Cell - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Urinary Bladder Neoplasms - therapy | Urinary Bladder Neoplasms - pathology | BCG Vaccine - therapeutic use | Adjuvants, Immunologic - therapeutic use | Muscle, Smooth - pathology | Mortality | Metastasis | Index Medicus
Journal Article